// Auto-updated clinical trials from ClinicalTrials.gov
// Last updated: 2026-02-16 09:37:43 UTC
const CLINICAL_TRIALS = [
  { nctId: "NCT06207032", title: "TEMPUS ARIES: A Biobank Registry Platform Study in Oncology", status: "RECRUITING", phase: "N/A", sponsor: "Tempus AI", conditions: "Cancer", enrollment: 500, lastUpdated: "2026-02-13" },
  { nctId: "NCT04981119", title: "Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR ", status: "RECRUITING", phase: "N/A", sponsor: "A2 Biotherapeutics Inc.", conditions: "Solid Tumor, Adult, Colorectal Cancer, Non Small C", enrollment: 200, lastUpdated: "2026-02-13" },
  { nctId: "NCT06883396", title: "JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligamen", status: "RECRUITING", phase: "N/A", sponsor: "Hospital for Special Surgery, New York", conditions: "Patellar Dislocation, Recurrent, Patellar Dislocat", enrollment: 850, lastUpdated: "2026-02-13" },
  { nctId: "NCT07400081", title: "Effectiveness of a Community-based Intervention Programme to Promote Well-being ", status: "NOT_YET_RECRUITING", phase: "NA", sponsor: "National Healthcare Group Polyclinics", conditions: "Well-being/Quality of Life, Mental Health", enrollment: 300, lastUpdated: "2026-02-13" },
  { nctId: "NCT06158828", title: "Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Deple", status: "RECRUITING", phase: "PHASE1, PHASE2", sponsor: "Washington University School of Medicine", conditions: "AML, Childhood, Aml, Acute Myeloid Leukemia, Pedia", enrollment: 68, lastUpdated: "2026-02-13" },
  { nctId: "NCT05954286", title: "PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19", status: "COMPLETED", phase: "PHASE2", sponsor: "Henry M. Jackson Foundation for the Advancement of Military Medicine", conditions: "SARS-CoV-2", enrollment: 92, lastUpdated: "2026-02-13" },
  { nctId: "NCT06647498", title: "A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or", status: "RECRUITING", phase: "PHASE2, PHASE3", sponsor: "Washington University School of Medicine", conditions: "Alzheimers Disease, Dementia, Alzheimers Disease, ", enrollment: 280, lastUpdated: "2026-02-13" },
  { nctId: "NCT07161037", title: "Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Ge", status: "RECRUITING", phase: "PHASE2", sponsor: "Vertex Pharmaceuticals Incorporated", conditions: "Autosomal Dominant Polycystic Kidney Disease (ADPK", enrollment: 24, lastUpdated: "2026-02-13" },
  { nctId: "NCT06712355", title: "Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Ch", status: "RECRUITING", phase: "PHASE3", sponsor: "BioNTech SE", conditions: "Extensive-stage Small-cell Lung Cancer", enrollment: 621, lastUpdated: "2026-02-13" },
  { nctId: "NCT05985655", title: "Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors", status: "RECRUITING", phase: "PHASE1, PHASE2", sponsor: "Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.", conditions: "Head and Neck Squamous Cell Carcinoma (HNSCC), Pan", enrollment: 230, lastUpdated: "2026-02-12" },
  { nctId: "NCT07403669", title: "Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment", status: "RECRUITING", phase: "NA", sponsor: "Aventyn, Inc.", conditions: "Acute MI, Heart Failure, Diabetes Mellitus", enrollment: 300, lastUpdated: "2026-02-12" },
  { nctId: "NCT07052305", title: "NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel", status: "RECRUITING", phase: "PHASE1", sponsor: "Washington University School of Medicine", conditions: "Large B-cell Lymphoma", enrollment: 24, lastUpdated: "2026-02-12" },
  { nctId: "NCT04993742", title: "Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative St", status: "ACTIVE_NOT_RECRUITING", phase: "NA", sponsor: "Henry M. Jackson Foundation for the Advancement of Military Medicine", conditions: "Placental Dysfunction, Prenatal Stress", enrollment: 150, lastUpdated: "2026-02-12" },
  { nctId: "NCT06016569", title: "Study of Early Cancer Biomarkers in Breath Condensate in Population of Individua", status: "RECRUITING", phase: "NA", sponsor: "The Institute of Molecular and Translational Medicine, Czech Republic", conditions: "Lung Cancer", enrollment: 3200, lastUpdated: "2026-02-12" },
  { nctId: "NCT06854393", title: "Lacripep for Corneal Wound Healing Study", status: "RECRUITING", phase: "PHASE2", sponsor: "Henry M. Jackson Foundation for the Advancement of Military Medicine", conditions: "Corneal Epithelial Wound Healing", enrollment: 88, lastUpdated: "2026-02-12" },
  { nctId: "NCT04486378", title: "A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Wa", status: "RECRUITING", phase: "PHASE2", sponsor: "BioNTech SE", conditions: "Colorectal Cancer Stage II, Colorectal Cancer Stag", enrollment: 327, lastUpdated: "2026-02-12" },
  { nctId: "NCT04534205", title: "A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects", status: "RECRUITING", phase: "PHASE2, PHASE3", sponsor: "BioNTech SE", conditions: "Unresectable Head and Neck Squamous Cell Carcinoma", enrollment: 350, lastUpdated: "2026-02-12" },
  { nctId: "NCT05968326", title: "A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizu", status: "RECRUITING", phase: "PHASE2", sponsor: "Genentech, Inc.", conditions: "Adenocarcinoma, Pancreatic Ductal", enrollment: 260, lastUpdated: "2026-02-12" },
  { nctId: "NCT07401940", title: "HAVEN-Connect Youth Suicide Prevention", status: "RECRUITING", phase: "NA", sponsor: "George Washington University", conditions: "Suicide Prevention", enrollment: 240, lastUpdated: "2026-02-11" },
  { nctId: "NCT06240754", title: "Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and M", status: "RECRUITING", phase: "PHASE2", sponsor: "Washington University School of Medicine", conditions: "Clonal Cytopenia of Undetermined Significance, CCU", enrollment: 15, lastUpdated: "2026-02-11" },
  { nctId: "NCT05944562", title: "Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome", status: "ACTIVE_NOT_RECRUITING", phase: "PHASE1", sponsor: "Washington University School of Medicine", conditions: "Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoi", enrollment: 24, lastUpdated: "2026-02-11" },
  { nctId: "NCT06940687", title: "Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and The", status: "ENROLLING_BY_INVITATION", phase: "NA", sponsor: "Yale University", conditions: "Alzheimer Disease, Dementia, Mild Cognitive Impair", enrollment: 60, lastUpdated: "2026-02-11" },
  { nctId: "NCT07349394", title: "Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosu", status: "RECRUITING", phase: "PHASE1", sponsor: "Vertex Pharmaceuticals Incorporated", conditions: "Cystic Fibrosis", enrollment: 18, lastUpdated: "2026-02-11" },
  { nctId: "NCT06747572", title: "Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Pol", status: "ACTIVE_NOT_RECRUITING", phase: "N/A", sponsor: "Vertex Pharmaceuticals Incorporated", conditions: "Autosomal Dominant Polycystic Kidney Disease (ADPK", enrollment: 401, lastUpdated: "2026-02-11" },
  { nctId: "NCT06750185", title: "Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for A", status: "RECRUITING", phase: "PHASE1", sponsor: "BioNTech SE", conditions: "Advanced Solid Tumor", enrollment: 39, lastUpdated: "2026-02-11" },
  { nctId: "NCT07070232", title: "A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe a", status: "RECRUITING", phase: "PHASE1, PHASE2", sponsor: "BioNTech SE", conditions: "Advanced Solid Tumor", enrollment: 980, lastUpdated: "2026-02-11" },
  { nctId: "NCT07222384", title: "A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in C", status: "ACTIVE_NOT_RECRUITING", phase: "PHASE3", sponsor: "BioNTech SE", conditions: "COVID-19, SARS-COV-2 Infection", enrollment: 343, lastUpdated: "2026-02-11" },
  { nctId: "NCT04503278", title: "A Clinical Study of the Safety and Effectiveness of an Investigational Cell Ther", status: "RECRUITING", phase: "PHASE1", sponsor: "BioNTech Cell & Gene Therapies GmbH", conditions: "Solid Tumor", enrollment: 214, lastUpdated: "2026-02-11" },
  { nctId: "NCT06892548", title: "A Clinical Study to Investigate the Efficacy and Safety of an Investigational Co", status: "RECRUITING", phase: "PHASE1, PHASE2", sponsor: "BioNTech SE", conditions: "Advanced Lung Cancer", enrollment: 594, lastUpdated: "2026-02-11" },
  { nctId: "NCT05673018", title: "Galleri® in the Medicare Population.", status: "RECRUITING", phase: "NA", sponsor: "GRAIL, Inc.", conditions: "Cancer", enrollment: 50000, lastUpdated: "2026-02-10" },
  { nctId: "NCT06119425", title: "Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Pract", status: "COMPLETED", phase: "NA", sponsor: "Ballad Health", conditions: "Cancer Colon", enrollment: 231, lastUpdated: "2026-02-10" },
  { nctId: "NCT07231419", title: "Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With ", status: "RECRUITING", phase: "PHASE3", sponsor: "Vertex Pharmaceuticals Incorporated", conditions: "Diabetic Peripheral Neuropathic Pain", enrollment: 734, lastUpdated: "2026-02-10" },
  { nctId: "NCT07291076", title: "A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combina", status: "NOT_YET_RECRUITING", phase: "PHASE1, PHASE2", sponsor: "Bristol-Myers Squibb", conditions: "Hepatocellular Carcinoma (HCC)", enrollment: 129, lastUpdated: "2026-02-10" },
  { nctId: "NCT07221357", title: "A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che", status: "RECRUITING", phase: "PHASE2, PHASE3", sponsor: "Bristol-Myers Squibb", conditions: "Untreated, Unresectable, or Metastatic Colorectal ", enrollment: 990, lastUpdated: "2026-02-10" },
  { nctId: "NCT05257551", title: "Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study", status: "RECRUITING", phase: "N/A", sponsor: "Tempus AI", conditions: "Small Cell Lung Cancer", enrollment: 50, lastUpdated: "2026-02-09" },
  { nctId: "NCT05423418", title: "Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A24", status: "COMPLETED", phase: "PHASE1", sponsor: "U.S. Army Medical Research and Development Command", conditions: "Human Immunodeficiency Virus (HIV), AIDS Virus", enrollment: 65, lastUpdated: "2026-02-09" },
  { nctId: "NCT05003817", title: "Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventr", status: "ACTIVE_NOT_RECRUITING", phase: "PHASE3", sponsor: "Guy's and St Thomas' NHS Foundation Trust", conditions: "Ischemic Heart Disease, Coronary Artery Disease", enrollment: 300, lastUpdated: "2026-02-09" },
  { nctId: "NCT04015700", title: "Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unme", status: "ACTIVE_NOT_RECRUITING", phase: "PHASE1", sponsor: "Washington University School of Medicine", conditions: "Glioblastoma", enrollment: 9, lastUpdated: "2026-02-09" },
  { nctId: "NCT05668741", title: "A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)", status: "RECRUITING", phase: "PHASE1, PHASE2", sponsor: "Vertex Pharmaceuticals Incorporated", conditions: "Cystic Fibrosis", enrollment: 39, lastUpdated: "2026-02-09" },
  { nctId: "NCT06534983", title: "A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab", status: "RECRUITING", phase: "PHASE2", sponsor: "Hoffmann-La Roche", conditions: "Muscle-invasive Urothelial Carcinoma", enrollment: 362, lastUpdated: "2026-02-09" },
];
